Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waveland Technologies was a private healthcare technology company focused on AI-enhanced data curation, insurance discovery, eligibility verification, patient demographic correction, and revenue cycle management workflows for healthcare providers, laboratories, and billing organizations. The company appears to have operated commercially under brands including Wave HDC and WavelandRCM rather than as a therapeutics developer. Its software was designed to improve front-end patient access and claims accuracy by identifying insurance coverage and validating demographic information in real time. In November 2023, Wave HDC/Waveland Technologies was acquired by Experian Health, and its capabilities were subsequently integrated into Experian Health's product suite. The business is healthcare-related, but it is not a biotech, pharma, or drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waveland Technologies.